CHS Inc.
CHS Inc. (CHSCN) Stock Competitors & Peer Comparison
See (CHSCN) competitors and their performances in Stock Market.
Peer Comparison Table: Agricultural Farm Products Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| CHSCN | $25.47 | -0.00% | 312.6M | N/A | N/A | +7.30% |
| ADM | $68.86 | +0.00% | 32.6B | 30.43 | $2.23 | +3.00% |
| BG | $123.49 | +0.00% | 23.6B | 28.77 | $4.24 | +2.29% |
| TSN | $64.33 | +0.00% | 22.8B | 114.11 | $0.56 | +3.15% |
| SFD | $24.80 | +0.00% | 9.8B | 11.28 | $2.22 | +4.00% |
| AGRO | $8.90 | +0.00% | 4.6B | 38.33 | $0.24 | +3.80% |
| CALM | $83.58 | +0.00% | 4B | 3.54 | $23.67 | +9.46% |
| IBA | $53.00 | -1.82% | 2.6B | 7.77 | $6.82 | +1.84% |
| FDP | $42.35 | +0.00% | 2B | 25.27 | $1.64 | +2.91% |
| DOLE | $15.97 | +0.00% | 1.5B | 12.69 | $1.26 | +2.09% |
Stock Comparison
CHSCN vs ADM Comparison February 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 312.6M. In comparison, ADM has a market cap of 32.6B. Regarding current trading prices, CHSCN is priced at $25.47, while ADM trades at $68.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas ADM's P/E ratio is 30.43. In terms of profitability, CHSCN's ROE is +0.06%, compared to ADM's ROE of +0.05%. Regarding short-term risk, CHSCN is less volatile compared to ADM. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check ADM's competition here
CHSCN vs BG Comparison February 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 312.6M. In comparison, BG has a market cap of 23.6B. Regarding current trading prices, CHSCN is priced at $25.47, while BG trades at $123.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas BG's P/E ratio is 28.77. In terms of profitability, CHSCN's ROE is +0.06%, compared to BG's ROE of +0.06%. Regarding short-term risk, CHSCN is less volatile compared to BG. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check BG's competition here
CHSCN vs TSN Comparison February 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 312.6M. In comparison, TSN has a market cap of 22.8B. Regarding current trading prices, CHSCN is priced at $25.47, while TSN trades at $64.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas TSN's P/E ratio is 114.11. In terms of profitability, CHSCN's ROE is +0.06%, compared to TSN's ROE of +0.01%. Regarding short-term risk, CHSCN is less volatile compared to TSN. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check TSN's competition here
CHSCN vs SFD Comparison February 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 312.6M. In comparison, SFD has a market cap of 9.8B. Regarding current trading prices, CHSCN is priced at $25.47, while SFD trades at $24.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas SFD's P/E ratio is 11.28. In terms of profitability, CHSCN's ROE is +0.06%, compared to SFD's ROE of +0.00%. Regarding short-term risk, CHSCN is less volatile compared to SFD. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check SFD's competition here
CHSCN vs AGRO Comparison February 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 312.6M. In comparison, AGRO has a market cap of 4.6B. Regarding current trading prices, CHSCN is priced at $25.47, while AGRO trades at $8.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas AGRO's P/E ratio is 38.33. In terms of profitability, CHSCN's ROE is +0.06%, compared to AGRO's ROE of +0.02%. Regarding short-term risk, CHSCN is less volatile compared to AGRO. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check AGRO's competition here
CHSCN vs CALM Comparison February 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 312.6M. In comparison, CALM has a market cap of 4B. Regarding current trading prices, CHSCN is priced at $25.47, while CALM trades at $83.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas CALM's P/E ratio is 3.54. In terms of profitability, CHSCN's ROE is +0.06%, compared to CALM's ROE of +0.45%. Regarding short-term risk, CHSCN is less volatile compared to CALM. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check CALM's competition here
CHSCN vs IBA Comparison February 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 312.6M. In comparison, IBA has a market cap of 2.6B. Regarding current trading prices, CHSCN is priced at $25.47, while IBA trades at $53.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas IBA's P/E ratio is 7.77. In terms of profitability, CHSCN's ROE is +0.06%, compared to IBA's ROE of +0.12%. Regarding short-term risk, CHSCN is less volatile compared to IBA. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check IBA's competition here
CHSCN vs FDP Comparison February 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 312.6M. In comparison, FDP has a market cap of 2B. Regarding current trading prices, CHSCN is priced at $25.47, while FDP trades at $42.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas FDP's P/E ratio is 25.27. In terms of profitability, CHSCN's ROE is +0.06%, compared to FDP's ROE of +0.05%. Regarding short-term risk, CHSCN is less volatile compared to FDP. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check FDP's competition here
CHSCN vs DOLE Comparison February 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 312.6M. In comparison, DOLE has a market cap of 1.5B. Regarding current trading prices, CHSCN is priced at $25.47, while DOLE trades at $15.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas DOLE's P/E ratio is 12.69. In terms of profitability, CHSCN's ROE is +0.06%, compared to DOLE's ROE of +0.01%. Regarding short-term risk, CHSCN is less volatile compared to DOLE. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check DOLE's competition here
CHSCN vs VITL Comparison February 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 312.6M. In comparison, VITL has a market cap of 1.2B. Regarding current trading prices, CHSCN is priced at $25.47, while VITL trades at $27.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas VITL's P/E ratio is 20.58. In terms of profitability, CHSCN's ROE is +0.06%, compared to VITL's ROE of +0.20%. Regarding short-term risk, CHSCN is less volatile compared to VITL. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check VITL's competition here
CHSCN vs VFF Comparison February 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 312.6M. In comparison, VFF has a market cap of 419.3M. Regarding current trading prices, CHSCN is priced at $25.47, while VFF trades at $3.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas VFF's P/E ratio is 72.60. In terms of profitability, CHSCN's ROE is +0.06%, compared to VFF's ROE of +0.08%. Regarding short-term risk, CHSCN is less volatile compared to VFF. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check VFF's competition here
CHSCN vs LND Comparison February 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 312.6M. In comparison, LND has a market cap of 396M. Regarding current trading prices, CHSCN is priced at $25.47, while LND trades at $3.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas LND's P/E ratio is 14.72. In terms of profitability, CHSCN's ROE is +0.06%, compared to LND's ROE of -0.04%. Regarding short-term risk, CHSCN is less volatile compared to LND. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check LND's competition here
CHSCN vs CHSCP Comparison February 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 312.6M. In comparison, CHSCP has a market cap of 345.9M. Regarding current trading prices, CHSCN is priced at $25.47, while CHSCP trades at $28.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas CHSCP's P/E ratio is N/A. In terms of profitability, CHSCN's ROE is +0.06%, compared to CHSCP's ROE of +0.06%. Regarding short-term risk, CHSCN is less volatile compared to CHSCP. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check CHSCP's competition here
CHSCN vs CHSCO Comparison February 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 312.6M. In comparison, CHSCO has a market cap of 322.6M. Regarding current trading prices, CHSCN is priced at $25.47, while CHSCO trades at $26.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas CHSCO's P/E ratio is N/A. In terms of profitability, CHSCN's ROE is +0.06%, compared to CHSCO's ROE of +0.06%. Regarding short-term risk, CHSCN is less volatile compared to CHSCO. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check CHSCO's competition here
CHSCN vs ALCO Comparison February 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 312.6M. In comparison, ALCO has a market cap of 316.8M. Regarding current trading prices, CHSCN is priced at $25.47, while ALCO trades at $40.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas ALCO's P/E ratio is -2.23. In terms of profitability, CHSCN's ROE is +0.06%, compared to ALCO's ROE of -1.27%. Regarding short-term risk, CHSCN is less volatile compared to ALCO. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check ALCO's competition here
CHSCN vs CHSCL Comparison February 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 312.6M. In comparison, CHSCL has a market cap of 314.5M. Regarding current trading prices, CHSCN is priced at $25.47, while CHSCL trades at $25.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas CHSCL's P/E ratio is N/A. In terms of profitability, CHSCN's ROE is +0.06%, compared to CHSCL's ROE of +0.06%. Regarding short-term risk, CHSCN is more volatile compared to CHSCL. This indicates potentially higher risk in terms of short-term price fluctuations for CHSCN.Check CHSCL's competition here
CHSCN vs CHSCM Comparison February 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 312.6M. In comparison, CHSCM has a market cap of 308.5M. Regarding current trading prices, CHSCN is priced at $25.47, while CHSCM trades at $25.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas CHSCM's P/E ratio is N/A. In terms of profitability, CHSCN's ROE is +0.06%, compared to CHSCM's ROE of +0.06%. Regarding short-term risk, CHSCN is less volatile compared to CHSCM. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check CHSCM's competition here
CHSCN vs AFRI Comparison February 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 312.6M. In comparison, AFRI has a market cap of 266.3M. Regarding current trading prices, CHSCN is priced at $25.47, while AFRI trades at $9.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas AFRI's P/E ratio is -12.69. In terms of profitability, CHSCN's ROE is +0.06%, compared to AFRI's ROE of -2.30%. Regarding short-term risk, CHSCN is less volatile compared to AFRI. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check AFRI's competition here
CHSCN vs LMNR Comparison February 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 312.6M. In comparison, LMNR has a market cap of 254.9M. Regarding current trading prices, CHSCN is priced at $25.47, while LMNR trades at $14.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas LMNR's P/E ratio is -15.13. In terms of profitability, CHSCN's ROE is +0.06%, compared to LMNR's ROE of -0.09%. Regarding short-term risk, CHSCN is less volatile compared to LMNR. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check LMNR's competition here
CHSCN vs AGFS Comparison February 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 312.6M. In comparison, AGFS has a market cap of 161.2M. Regarding current trading prices, CHSCN is priced at $25.47, while AGFS trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas AGFS's P/E ratio is -2.61. In terms of profitability, CHSCN's ROE is +0.06%, compared to AGFS's ROE of -0.12%. Regarding short-term risk, CHSCN is less volatile compared to AGFS. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check AGFS's competition here
CHSCN vs LOCL Comparison February 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 312.6M. In comparison, LOCL has a market cap of 39.3M. Regarding current trading prices, CHSCN is priced at $25.47, while LOCL trades at $1.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas LOCL's P/E ratio is -0.18. In terms of profitability, CHSCN's ROE is +0.06%, compared to LOCL's ROE of +0.97%. Regarding short-term risk, CHSCN is less volatile compared to LOCL. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check LOCL's competition here
CHSCN vs PME Comparison February 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 312.6M. In comparison, PME has a market cap of 23.2M. Regarding current trading prices, CHSCN is priced at $25.47, while PME trades at $0.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas PME's P/E ratio is 13.50. In terms of profitability, CHSCN's ROE is +0.06%, compared to PME's ROE of -0.03%. Regarding short-term risk, CHSCN is less volatile compared to PME. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check PME's competition here
CHSCN vs AFRIW Comparison February 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 312.6M. In comparison, AFRIW has a market cap of 20.6M. Regarding current trading prices, CHSCN is priced at $25.47, while AFRIW trades at $0.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas AFRIW's P/E ratio is -33.33. In terms of profitability, CHSCN's ROE is +0.06%, compared to AFRIW's ROE of -2.30%. Regarding short-term risk, CHSCN is less volatile compared to AFRIW. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check AFRIW's competition here
CHSCN vs APPHW Comparison February 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 312.6M. In comparison, APPHW has a market cap of 10.3M. Regarding current trading prices, CHSCN is priced at $25.47, while APPHW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas APPHW's P/E ratio is N/A. In terms of profitability, CHSCN's ROE is +0.06%, compared to APPHW's ROE of -0.55%. Regarding short-term risk, CHSCN is less volatile compared to APPHW. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check APPHW's competition here
CHSCN vs APPH Comparison February 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 312.6M. In comparison, APPH has a market cap of 10.3M. Regarding current trading prices, CHSCN is priced at $25.47, while APPH trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas APPH's P/E ratio is -0.14. In terms of profitability, CHSCN's ROE is +0.06%, compared to APPH's ROE of -0.55%. Regarding short-term risk, CHSCN is less volatile compared to APPH. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check APPH's competition here
CHSCN vs EDBLW Comparison February 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 312.6M. In comparison, EDBLW has a market cap of 4.6M. Regarding current trading prices, CHSCN is priced at $25.47, while EDBLW trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas EDBLW's P/E ratio is -0.08. In terms of profitability, CHSCN's ROE is +0.06%, compared to EDBLW's ROE of -1.63%. Regarding short-term risk, CHSCN is less volatile compared to EDBLW. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check EDBLW's competition here
CHSCN vs AQB Comparison February 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 312.6M. In comparison, AQB has a market cap of 3.4M. Regarding current trading prices, CHSCN is priced at $25.47, while AQB trades at $0.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas AQB's P/E ratio is -0.04. In terms of profitability, CHSCN's ROE is +0.06%, compared to AQB's ROE of -6.03%. Regarding short-term risk, CHSCN is less volatile compared to AQB. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check AQB's competition here
CHSCN vs SDOT Comparison February 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 312.6M. In comparison, SDOT has a market cap of 2.3M. Regarding current trading prices, CHSCN is priced at $25.47, while SDOT trades at $2.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas SDOT's P/E ratio is -0.12. In terms of profitability, CHSCN's ROE is +0.06%, compared to SDOT's ROE of -0.46%. Regarding short-term risk, CHSCN is less volatile compared to SDOT. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check SDOT's competition here
CHSCN vs KALWW Comparison February 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 312.6M. In comparison, KALWW has a market cap of 2.1M. Regarding current trading prices, CHSCN is priced at $25.47, while KALWW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas KALWW's P/E ratio is N/A. In terms of profitability, CHSCN's ROE is +0.06%, compared to KALWW's ROE of -0.19%. Regarding short-term risk, CHSCN is less volatile compared to KALWW. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check KALWW's competition here
CHSCN vs KAL Comparison February 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 312.6M. In comparison, KAL has a market cap of 2.1M. Regarding current trading prices, CHSCN is priced at $25.47, while KAL trades at $1.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas KAL's P/E ratio is -0.01. In terms of profitability, CHSCN's ROE is +0.06%, compared to KAL's ROE of -0.19%. Regarding short-term risk, CHSCN is less volatile compared to KAL. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check KAL's competition here
CHSCN vs AGRI Comparison February 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 312.6M. In comparison, AGRI has a market cap of 1.5M. Regarding current trading prices, CHSCN is priced at $25.47, while AGRI trades at $0.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas AGRI's P/E ratio is N/A. In terms of profitability, CHSCN's ROE is +0.06%, compared to AGRI's ROE of -2.70%. Regarding short-term risk, CHSCN is less volatile compared to AGRI. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check AGRI's competition here
CHSCN vs AVX Comparison February 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 312.6M. In comparison, AVX has a market cap of 1.5M. Regarding current trading prices, CHSCN is priced at $25.47, while AVX trades at $0.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas AVX's P/E ratio is N/A. In terms of profitability, CHSCN's ROE is +0.06%, compared to AVX's ROE of -2.70%. Regarding short-term risk, CHSCN is less volatile compared to AVX. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check AVX's competition here
CHSCN vs EDBL Comparison February 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 312.6M. In comparison, EDBL has a market cap of 985.7K. Regarding current trading prices, CHSCN is priced at $25.47, while EDBL trades at $3.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas EDBL's P/E ratio is 0.01. In terms of profitability, CHSCN's ROE is +0.06%, compared to EDBL's ROE of -1.63%. Regarding short-term risk, CHSCN is less volatile compared to EDBL. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check EDBL's competition here
CHSCN vs AAGR Comparison February 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 312.6M. In comparison, AAGR has a market cap of 572.9K. Regarding current trading prices, CHSCN is priced at $25.47, while AAGR trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas AAGR's P/E ratio is N/A. In terms of profitability, CHSCN's ROE is +0.06%, compared to AAGR's ROE of +3.27%. Regarding short-term risk, CHSCN is more volatile compared to AAGR. This indicates potentially higher risk in terms of short-term price fluctuations for CHSCN.Check AAGR's competition here
CHSCN vs DTCK Comparison February 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 312.6M. In comparison, DTCK has a market cap of 122.1K. Regarding current trading prices, CHSCN is priced at $25.47, while DTCK trades at $0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas DTCK's P/E ratio is -0.52. In terms of profitability, CHSCN's ROE is +0.06%, compared to DTCK's ROE of -0.60%. Regarding short-term risk, CHSCN is less volatile compared to DTCK. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check DTCK's competition here
CHSCN vs AGRIW Comparison February 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 312.6M. In comparison, AGRIW has a market cap of 66.2K. Regarding current trading prices, CHSCN is priced at $25.47, while AGRIW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas AGRIW's P/E ratio is -0.01. In terms of profitability, CHSCN's ROE is +0.06%, compared to AGRIW's ROE of -2.70%. Regarding short-term risk, CHSCN is less volatile compared to AGRIW. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check AGRIW's competition here
CHSCN vs AAGRW Comparison February 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 312.6M. In comparison, AAGRW has a market cap of 57.9K. Regarding current trading prices, CHSCN is priced at $25.47, while AAGRW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas AAGRW's P/E ratio is N/A. In terms of profitability, CHSCN's ROE is +0.06%, compared to AAGRW's ROE of +3.27%. Regarding short-term risk, CHSCN is less volatile compared to AAGRW. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCN.Check AAGRW's competition here
CHSCN vs SANW Comparison February 2026
CHSCN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCN stands at 312.6M. In comparison, SANW has a market cap of 43.2K. Regarding current trading prices, CHSCN is priced at $25.47, while SANW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCN currently has a P/E ratio of N/A, whereas SANW's P/E ratio is -0.01. In terms of profitability, CHSCN's ROE is +0.06%, compared to SANW's ROE of -0.58%. Regarding short-term risk, CHSCN is more volatile compared to SANW. This indicates potentially higher risk in terms of short-term price fluctuations for CHSCN.Check SANW's competition here